BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11475354)

  • 1. Peritoneal reaction to icodextrin in a female patient on CAPD.
    Heering P; Brause M; Plum J; Grabensee B
    Perit Dial Int; 2001; 21(3):321-2. PubMed ID: 11475354
    [No Abstract]   [Full Text] [Related]  

  • 2. Sodium removal in peritoneal dialysis: the role of icodextrin and peritoneal dialysis modalities.
    Fourtounas C; Hardalias A; Dousdampanis P; Papachristopoulos B; Savidaki E; Vlachojannis JG
    Adv Perit Dial; 2008; 24():27-31. PubMed ID: 18985997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of icodextrin-based peritoneal dialysis solution on peritoneal membrane.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2005; 21():21-4. PubMed ID: 16686279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of icodextrin on the peritoneal membrane. An inaccurate comment.
    Gotloib L
    Nephrol Dial Transplant; 2010 Sep; 25(9):3125-6; author reply 3126. PubMed ID: 20576721
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of icodextrin on the peritoneal membrane.
    Krediet RT
    Nephrol Dial Transplant; 2010 May; 25(5):1373-5. PubMed ID: 20172851
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy.
    Nakao A; Nakao K; Takatori Y; Kojo S; Inoue J; Akagi S; Sugiyama H; Wada J; Makino H
    Nephrol Dial Transplant; 2010 May; 25(5):1479-88. PubMed ID: 19759273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between effluent levels of beta(2)-microglobulin and peritoneal injury markers in 7.5% icodextrin-based peritoneal dialysis solution.
    Minami S; Hora K; Kamijo Y; Higuchi M
    Ther Apher Dial; 2007 Aug; 11(4):296-300. PubMed ID: 17661836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alternative dialysis solutions in continuous ambulatory peritoneal dialysis].
    Olszowska A; Baczyński D
    Pol Merkur Lekarski; 1998 Nov; 5(29):307-9. PubMed ID: 10101509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Falsely Elevated Glucose Concentrations in Peritoneal Dialysis Patients Using Icodextrin.
    Dogan K; Kayalp D; Ceylan G; Azak A; Senes M; Duranay M; Yucel D
    J Clin Lab Anal; 2016 Sep; 30(5):506-9. PubMed ID: 26511081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative dialysis strategies with icodextrin.
    Panzer SE; Teitelbaum I
    Contrib Nephrol; 2012; 178():11-15. PubMed ID: 22652709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icodextrin's effects on peritoneal transport.
    Krediet RT; Ho-dac-Pannekeet MM; Imholz AL; Struijk DG
    Perit Dial Int; 1997; 17(1):35-41. PubMed ID: 9068020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific characteristics of peritoneal leucocyte populations during sterile peritonitis associated with icodextrin CAPD fluids.
    Glorieux G; Lameire N; Van Biesen W; Dequidt C; Vanholder R
    Nephrol Dial Transplant; 2003 Aug; 18(8):1648-53. PubMed ID: 12897108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients.
    Gürsu EM; Ozdemir A; Yalinbas B; Gürsu RU; Canbakan M; Güven B; Atasoyu EM; Keskin AT; Elçi A; Baru Y
    Clin Nephrol; 2006 Oct; 66(4):263-8. PubMed ID: 17063993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of icodextrin-based dialysis solution on peritoneal leptin clearance.
    Opatrná S; Opatrný K; Racek J; Sefrna F
    Perit Dial Int; 2003; 23(1):89-91. PubMed ID: 12691516
    [No Abstract]   [Full Text] [Related]  

  • 17. A preceding exchange with polyglucose versus glucose solution modifies peritoneal equilibration test results.
    Lilaj T; Dittrich E; Puttinger H; Schneider B; Haag-Weber M; Hörl WH; Vychytil A
    Am J Kidney Dis; 2001 Jul; 38(1):118-26. PubMed ID: 11431191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient sterile chemical peritonitis in a CAPD patient using icodextrin.
    Goffin E; Scheiff JM
    Perit Dial Int; 2002; 22(1):90-1. PubMed ID: 11929151
    [No Abstract]   [Full Text] [Related]  

  • 19. Peritoneal clearance of homocysteine with icodextrin or standard glucose solution exchange.
    Czupryniak A; Nowicki M; Chwatko G; Jander A; Bald E
    Nephrology (Carlton); 2005 Dec; 10(6):571-5. PubMed ID: 16354239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of icodextrin on transperitoneal uric acid and albumin transport in vitro.
    Grzelak T; Szary B; Czyzewska K
    Adv Perit Dial; 2004; 20():47-50. PubMed ID: 15384794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.